EVALUATION CHANGES IN INDICATORS OF ONCOLOGICAL SERVICE IN CORPUS UTERI CANCER IN KAZAKHSTAN
DOI:
https://doi.org/10.54890/.v5i5-6.458Аннотация
Corpus uteri cancer is the sixth most common cancer worldwide. Approximately 417,367 new cases and 97,370 deaths of endometrial cancer occur annually worldwide. Moreover, in many countries such as Europe, the United States, Russia, and Canada, carcinoma of the corpus uteri (endometrial carcinoma) has now surpassed cervical carcinoma as the most common form of malignancy affecting the female genital tract.
The aim of the study was to evaluate some indicators of the oncological service in CUC in Kazakhstan in the period from 2009 to 2018.
The research material was data from the Ministry of Health of the Republic of Kazakhstan – annual form No. 7 and 35 regarding CUC (ICD 10 – C54) for 2009-2018 – incidence, mortality, early diagnosis, neglect, morphological verification. A retrospective study using descriptive and analytical methods of biomedical statistics was used as the main method. For 2009-2018, 10,522 new cases of CUC were registered in the republic for the first time and 2,774 women died from this disease. The average annual crude incidence rate of CUC was 11.9±0.30/0000 (95% CI=11.3-12.5) and increased in dynamics from 10.7±0.40/0000 (2009) to 11.6±0.40/0000 in 2018, the difference was statistically significant (t=1.59 and p=0.112). In dynamics, mortality rates from CUC tended to statistically significant (t=3.89 and p=0.000) decrease from 3.6±0.20/0000 (2009) to 2.5±0.20/0000 in 2018, and the average annual crude mortality rate from corpus uteri cancer was 3.2±0.20/0000 (95% CI=2.9-3.5). The research of the study period reveals a trend: early diagnosis indicators (specific weight of patients with I-II stage) improved from 82.0% (2009) to 88.6% in 2018, and accordingly the specific weight of neglected patients significantly decreased with stage III (from 12.0% to 8.5%) and with stage IV (from 4.7% to 2.8%). The morphological verification indicators for CUC remained virtually unchanged, remaining fairly high 98.6% and 98.8%,respectively, in 2009 and 2018.
Conclusion. An analysis of the indicators of the oncological service in CUC revealed an improvement in morphological verification and early diagnosis, a decrease in neglect and mortality rates, which is undoubtedly associated with regular anti-cancer activities in Kazakhstan.
Ключові слова:
corpus uteri cancer, incidence, mortality, early diagnosis, neglect, morphological verification, Kazakhstan.Посилання
1. Ferlay J, Ervik M, Lam F, et al. (2020A). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today.
2. Bray F, Loos AH, Oostindier M, Weiderpass E. Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe. Int J Cancer. 2005;117(1):123–131.
3. Xi Y, Wang W, Chen W, Han K, Qiao L, Chen W. Incidence and mortality of corpus uteri cancer in China, 2008-2012. Chin J Cancer Res. 2019;31(3):435-442. doi:10.21147/j.issn.1000-9604.2019.03.05.
4. Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2018;143 Suppl 2:37-50. doi:10.1002/ijgo.12612.
5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
6. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
7. Chaichian S, Khateri S, Moradi Y, Shadmani FK, Mansori K, Khazaei Z, et al. Trends in cervical cancer incidence in Iran from 2003 to 2009. Middle East J Cancer. 2017;9:57–63.
8. Torres-Cintrón M, Ortiz AP, Ortiz-Ortiz KJ, Figueroa-Vallés NR, Pérez-Irizarry J, Díaz-Medina G, et al. Using a socioeconomic position index to assess disparities in cancer incidence and mortality, Puerto Rico, 1995–2004. Prev Chronic Dis. 2012;9:E15.
9. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J
10. Goodarzi E, Moslem A, Feizhadad H, Jarrahi AM, Adineh HA, Sohrabivafa M, et al. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: an ecology study in 2018. Adv Hum Biol. 2019;9:162–167.
11. Khazaei Z, Goodarzi E, Sohrabivafa M, Naemi H, Mansori K. Association between the incidence and mortality rates for corpus uteri cancer and human development index (HDI): a global ecological study. Obstet Gynecol Sci. 2020;63(2):141-149. doi:10.5468/ogs.2020.63.2.141.
12. Seebacher V, Schmid M, Polterauer S, Frischmuth KH, Leipold H, et al. The presence of post-menopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multinational study. BMC Cancer. 2009;9:460-69.
13. Merkov AM, Polyakov LE. Sanitarnaya statistika (Sanitary statistics) [in Russian]. Leningrad: Medicine. – 1974. – 384 p.
14. Glanc S. Mediko-biologicheskaya statistika (Biomedical statistics) [in Russian]. Moscow: Practice. – 1999. – 460 p.